Skip to content

Clinical study on biomarkers of acute ischemic stroke

Clinical study on the construction of early warning system for ischemic stroke

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100045815
Enrollment
Unknown
Registered
2021-04-25
Start date
2021-04-25
Completion date
Unknown
Last updated
2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ischemic stroke

Interventions

Group with carotid plaque:no
No carotid plaque group:no

Sponsors

South China Hospital of University of South China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years; 2. AIS is diagnosed by neurologists through head CT or MRI, and acute cerebral infarction is in accordance with the "Chinese Acute Ischemic Stroke Diagnosis and Treatment Guide 2018" formulated by the Neurology Branch of the Chinese Medical Association; 3. Accept carotid artery ultrasound examination within 7 days of admission; 4. Participate in this research voluntarily and voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. The onset time is more than 7 days, combined with other serious primary diseases; 2. TIA; 3. Have taken drugs that affect lipid metabolism and renal function within one month; 4. Combined with severe infection, abnormal liver and kidney function or autoimmune diseases; 5. There are many data missing.

Design outcomes

Primary

MeasureTime frame
Angiopoietin-like protein 4;Apolipoprotein CIII;Retinol binding protein 4;ß2 microglobulin;Triglyceride lipoprotein cholesterol;

Countries

China

Contacts

Public ContactYu Shan

Nanhua Hospital Affiliated to Nanhua University

yushan8725@163.com+86 17382117793

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026